VENTALEON
Ventaleon is developing inhaled treatments against viral infections. The Company’s lead therapy, is an inhaled LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well-known acetyl salicylic acid (Aspirin®), suitable as an ingredient for inhalable aerosol, has completed Phase II clinical trials to treat severe influenza. A proof-of-concept study in influenza patients with moderate to severe symptoms demonstrated more rapid symptom decline when administered via inhaled LASAG compared to standard of care. The Company is currently preparing to enter a pivotal clinical trial with inhaled LASAG. Ventaleon was founded as a spin-off from Activaero, a leading specialist in aerosol inhalation therapies and technologies, in 2012
VENTALEON
Industry:
Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
Gemünden, Bayern, Germany
Country:
Germany
Website Url:
http://www.ventaleon.com
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
SPF Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS DigiCert SSL Parallels Plesk Panel Encryption Everywhere InterNetX DNS InterNetX
Similar Organizations
AAVantgarde Bio
AAVantgarde Bio is developing gene therapies for inherited retinal disorders.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Stayble Therapeutics
Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.
Investors List
LSP BioVentures
LSP BioVentures investment in Venture Round - Ventaleon
Abalis Finance
Abalis Finance investment in Venture Round - Ventaleon
BayBG Venture Capital
BayBG Venture Capital investment in Venture Round - Ventaleon
Official Site Inspections
http://www.ventaleon.com Semrush global rank: 7.11 M Semrush visits lastest month: 192
- Host name: saturn.cycom.it
- IP address: 85.236.63.4
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
